Download App
Help CenterSubscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Bio Medica Laboratories Ltd (BMLL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: BMLL Pharmaceuticals & Drugs | Small Cap | Bio Medica Labs. Share Price

BSE Share Price
Not Listed

Bio Medica Laboratories Ltd (BMLL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: BMLL Pharmaceuticals & Drugs | Small Cap | Bio Medica Labs. Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹207 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
54.9
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
150.49%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
67.70%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹12.6 Cr.
Face Value
₹10
All Time Low / High
₹0.00 / 0.00

Bio Medica Laboratories stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Not Good
Check detailed performance

Valuation

Overvalued

Check Valuation charts

Price Trend

Strong
Check Price chart
Q.1 Is Bio Medica Laboratories Ltd a good quality company?
Bio Medica Laboratories Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Bio Medica Laboratories Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Bio Medica Laboratories Ltd vs industry peers?
Bio Medica Laboratories Ltd revenue CAGR is %, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Q.1 Promoter shareholding and pledge status of Bio Medica Laboratories Ltd?
Promoters hold 67.70% of the Bio Medica Laboratories Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Bio Medica Laboratories Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.
View More

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bio Medica Laboratories Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'23Mar'24Mar'25TTM
ROCE % ⓘ10.2%33.6%64.2%-
Value Creation
Index ⓘ		-0.31.43.6-

Growth Parameters ⓘ
Sales ⓘ16.215.338.238
Sales YoY Gr.--6%150.5%-
Adj EPS ⓘ0.42.710.79.3
YoY Gr.-655.6%292.3%-
BVPS (₹) ⓘ2.75.416.149.2
Adj Net
Profit ⓘ		0.32.59.812
Cash Flow from Ops. ⓘ2.31.6-3.7-
Debt/CF from Ops. ⓘ4.26.5-4.1-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNANANA150.5%
Adj EPS ⓘNANANA292.3%
BVPSⓘNANANA198.3%
Share Price - - - -

Key Financial Parameters ⓘ

Mar'23Mar'24Mar'25TTM
Return on
Equity % ⓘ		13.767.799.628.4
Op. Profit
Mgn % ⓘ		10.536.940.3NAN
Net Profit
Mgn % ⓘ		2.116.425.630.5
Debt to
Equity ⓘ		3.92.11-
Working Cap
Days ⓘ		02382000
Cash Conv.
Cycle ⓘ		01031040

Valuation of Bio Medica Labs. - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

data not found
No data found!
data
No data found!
data
No data found!
data
No data found!

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Bio Medica Laboratories Ltd FAQs

The current trading price of Bio Medica Labs. on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Bio Medica Labs. stood at ₹206.9 Cr

The latest P/E ratio of Bio Medica Labs. as of 31-Dec-1969 is 17.73.

The latest P/B ratio of Bio Medica Labs. as of 31-Dec-1969 is 3.34.

The 52-week high of Bio Medica Labs. is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bio Medica Labs. is ₹38.30 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Bio Medica Laboratories Ltd is a below average quality company.

The key valuation ratios of Bio Medica Laboratories Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Bio Medica Laboratories Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Bio Medica Laboratories Ltd

Bio Medica Laboratories was originally incorporated as a private limited company with the name of ‘Bio Medica Laboratories Private Limited’ under the Companies Act, 2013 vide certificate of incorporation dated August 14, 2015, issued by Registrar of Companies, Gwalior. Further, the company was converted into a Public Limited Company in pursuance of a special resolution passed by the members of the Company at the Extra- Ordinary General Meeting held on September 09, 2024 & name of the company changed from ‘Bio Medica Laboratories Private Limited’ to ‘Bio Medica Laboratories Limited’ & Registrar of Companies, CPC has issued a new certificate of incorporation consequent upon conversion dated October 24, 2024.

Bio Medica Laboratories is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences. The company operates on a B2B business model through contract manufacturing and does not deal directly with the end users. The company manufactures formulations for various companies according to their specific requirements and specifications for the type of formulation needed. Additionally, it enters into agreements with them, allowing their name and address to be displayed on the packaging as ‘Technical Collaborator’ or ‘marketed by’ alongside the company’s name as the manufacturer.

The company holds Good Manufacturing Practices (GMP) certificate issued by Food & Drugs Administration, Madhya Pradesh, for complying with established GMP standards and guidelines. The company maintain stringent quality control standards throughout the entire manufacturing process. 

Business area of the company

Bio Medica Laboratories is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences.

Products of the company

Liquid injectables

  • 100ml Amikacin Sulphate IP injection
  • Vitamin B12, D3 & Calcium Gluconolactobionate injection
  • 2ml Amikacin Sulphate injection
  • Buprenorphine injection
  • 30ml Amikacin Sulphate injection

Dry Powder Injectables

  • Piperacillin & Tazobactam injection
  • Ceftrixone & Sulbactam for injection
  • Meropenem injection
  • Ceftriaxone injection
  • Artesunate injection

History and milestones

  • 2015: Incorporation of Company.
  • 2024: Alteration of Name clause of Memorandum of Association and subsequently Conversion of the Company from Private Limited Company into Public Limited Company.

You have 43 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now